Top Ten Common Prejudices About Polyethylene Naphthalate Market.

-
Image
In 2014, the global polyethylene naphthalate market was worth USD 827.0 million, and it is expected to grow at a CAGR of 7.5 percent over the next five years. Because of its improved thermal and barrier properties, such as oxidation resistance, polyethylene naphthalate (PEN) is primarily used in packaging applications. Over the forecast period, rising demand for high-strength photographic films is likely to drive market expansion. polyethylene naphthalate market Because of their higher stiffness modulus, PEN films are a major component of food packaging applications, providing increased barrier properties and enhancing the material's strength. These films are also used to make pressure sensitive tapes and thermal sheets. They are also involved in the protection of solar cells. Forward integration of raw material providers in PEN manufacturing is a feature of the polyethylene naphthalate market. These businesses actively consume raw materials in order to create their products. Con...
1 comment

Understanding The Background Of Insulin Delivery Devices Market.

-


The global market for insulin delivery devices is expected to reach USD 17.85 billion by 2021, up from USD 11.54 billion in 2016, with a CAGR of 9.1% over the forecast period. The advantageous reimbursement scenario and strong government backing in selected countries, technological improvements in insulin delivery devices, a growing diabetes population, and rising knowledge of insulin delivery devices all contributed to the overall market's rise.

The market is predicted to develop at the fastest rate in the Asia-Pacific region in the coming years. The Asia-Pacific insulin delivery devices market is predicted to develop due to factors such as rising diabetes prevalence, high uptake of insulin pens, and government initiatives in Singapore.

The vices market is divided into pens, pumps, pen needles, syringes, and other devices based on kind (jet injectors, transdermal patches, and inhalers). The insulin pens market is further divided into disposable and reusable insulin pens. In 2016, the market for insulin pens was dominated by the reusable category. External/tethered pumps and patch pumps are two types of pumps in the pumps category. The external/tethered pumps sector accounted for the majority of the insulin pump market in 2016. The patch pumps market, on the other hand, is predicted to develop at the fastest rate over the forecast period. The market for pen needles is divided into two categories: normal pen needles and safety pen needles.

The insulin delivery devices market is divided into two segments based on end users: patients/homecare and hospitals & clinics. The patients/homecare sector held the greatest market share in 2016.

North America held the greatest share of the global market in 2016. The rising prevalence of diabetes, favourable reimbursement scenarios in the United States and Canada, increasing venture capital investments and IPOs in the United States, and FDA approvals to increase the commercial availability of insulin delivery devices in the United States are all contributing to this growth.

Becton, Dickinson and Company (US), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), Medtronic plc (Ireland), Animas Corporation (US), Tandem Diabetes Care, Inc. (US), Sanofi (France), Biocon Ltd. (India), Eli Lilly and Company (US), and Insulet Corporation are among the major players in the global insulin delivery devices market (U.S.).

Additional market players will be profiled and analysed in detail (up to 3)

The market for insulin delivery devices is expected to reach USD 17.85 billion by 2021, up from USD 11.54 billion in 2016, with a CAGR of 9.1% during the forecast period. Favorable reimbursement scenarios and government backing in a few countries, technological developments in insulin delivery systems, and an increasing diabetes population are all key market drivers.

The global market is divided into three categories: category, end user, and geography. The market is divided into pens, pumps, pen needles, syringes, and other devices based on their type (jet injectors, transdermal patches, and inhalers). Insulin pens accounted for the highest share of the global insulin delivery devices market in 2016. Insulin pens are categorised into two categories: reusable pens and disposable pens. In 2016, the market for insulin pens was dominated by the reusable category. External/tethered pumps and patch pumps are two types of pumps in the pumps category. The external/tethered pumps category accounted for the majority of the insulin pumps market in 2016.

The market is divided into two segments based on the end user: patients/homecare and hospitals & clinics. Patients/homecare held the greatest share of the insulin delivery devices market in 2016 and is predicted to grow at the fastest CAGR during the forecast period. The growing diabetes population and rising healthcare costs are responsible for this segment's rise.

North America held the greatest proportion of the global market for insulin delivery devices in 2016. The growing prevalence of diabetes and favourable reimbursement scenario in the United States and Canada, growing venture capital investments and IPOs in the United States, and FDA approvals to increase the commercial availability of insulin delivery devices in the United States all contribute to this segment's large share.

Becton, Dickinson and Company (US), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), Medtronic plc (Ireland), Animas Corporation (US), Tandem Diabetes Care, Inc. (US), Sanofi (France), Biocon Ltd. (India), Eli Lilly and Company (US), and Insulet Corporation are some of the major players in the global Insulin Delivery Devices Market (U.S.).

Comments

Post a Comment

Popular posts from this blog

Top Ten Common Prejudices About Polyethylene Naphthalate Market.

-
Image
In 2014, the global polyethylene naphthalate market was worth USD 827.0 million, and it is expected to grow at a CAGR of 7.5 percent over the next five years. Because of its improved thermal and barrier properties, such as oxidation resistance, polyethylene naphthalate (PEN) is primarily used in packaging applications. Over the forecast period, rising demand for high-strength photographic films is likely to drive market expansion. polyethylene naphthalate market Because of their higher stiffness modulus, PEN films are a major component of food packaging applications, providing increased barrier properties and enhancing the material's strength. These films are also used to make pressure sensitive tapes and thermal sheets. They are also involved in the protection of solar cells. Forward integration of raw material providers in PEN manufacturing is a feature of the polyethylene naphthalate market. These businesses actively consume raw materials in order to create their products. Con...
Read more

10 Benefits Of Paper And Packaging Market That May Change Your Perspective.

-
Image
The paper packaging market during the projection period of 2021-2026, the paper packaging market grew at a CAGR of 3.87 percent. The COVID-19 epidemic wreaked havoc on the packaging sector, with the impacts of nationwide lockdown, corporations shifting their sourcing away from China, and materials used in packaging being reconsidered. Although there has been a substantial impact on the supply side of paper packaging, a large growth in end-user demand in specific applications has significantly expanded the scope of paper packaging. Paper packaging is a flexible and cost-effective way to protect, store, and transport a variety of items. It can also be tailored to match the needs of certain customers or products. The characteristics of paper packaging, such as lightweight, biodegradability, and recyclability, make it a crucial component for packaging. The market for paper packaging is being driven by rising consumer awareness of sustainable packaging and tight rules enforced by various en...
Read more

5 Various Ways To Do Obesity Management Drugs Market.

-
Image
Obesity is a medical disorder in which the body accumulates too much fat. Excessive food intake, hereditary vulnerability, and a lack of physical activity are all frequent causes of the Obesity Management Drugs Market . Bupropion and Naltrexone, Orlistat, Lorcaserin, Phentermine and Topiramate, and Liraglutide are some of the drugs used to treat obesity. Over the forecast period, the worldwide Obesity Management Drugs Market is expected to rise due to the high prevalence of obesity. According to MedAlertHelp.org, nearly 1.9 billion adults globally are considered overweight. Furthermore, obesity R&D is expected to contribute to the global obesity management drugs market's growth. According to a short study to be presented at e-ECE 2020, the 22nd European Congress of Endocrinology, the probiotic strain Bifidobacterium breve, when combined with a calorie-controlled diet, may aid in the weight loss of obese children and adolescents. The global obesity treatment pharmaceuticals ma...
Read more